ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

EUDA vs DCGO // REVENUE GROWTH (YOY)

EUDA Health Holdings Limited (NASDAQ) VS. DocGo Inc. (NASDAQ) • 15-METRIC TALLY: EUDA 5 — DCGO 1
▲ REVENUE GROWTH (YOY) LEADER: EUDA
revenue-growth
70.00%
revenue-growth
-47.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EUDA VS. DCGO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC EUDA DCGO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 43.90% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -5.39% — — TIE /fcf-yield <GO>
Operating Margin -36.30% -55.30% +19.00 EUDA /operating-margins <GO>
Net Profit Margin -40.70% -60.00% +19.30 EUDA /net-margins <GO>
Revenue Growth (YoY) ACTIVE 70.00% -47.70% +117.70 EUDA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 5/9 -1.00 DCGO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 49.3 39.1 +10.20 EUDA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $46.4M $27.0M $19.4M EUDA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR EUDA REV DCGO REV EUDA GROSS % DCGO GROSS % EUDA FCF DCGO FCF
FY 2025 $6.8M $322.2M 43.9% — -$2.5M $29.9M
FY 2024 $4.0M $616.6M 19.0% — -$2.1M $66.5M
FY 2023 $3.7M $624.3M — — -$2.9M -$64.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EUDA // BETA —
DCGO // BETA —